Companies /Healthcare

Sarepta Therapeutics Inc

NASDAQ: SRPT Biotechnology
$21.59
â–² $2.13 (+10.95%) today
Markets closed · 3:16am ET
24/7 Rating SELL
12-Month Price Target
$13.28 −35.2% downside

Set by 24/7 Wall St.’s proprietary analysis of professional targets, profit trajectory, sector, risk, and retail attention. How we calculate our price targets →

Current close $20.51
Street consensus $22.09
Ours vs. the Street −39.9%
$12.25Conservative$20.51Current$13.28Our Target$18.14Optimistic
12-Month Projection Historical Optimistic Target Conservative
$12$16$20$24Aug 2025Aug 2027Today$18.14$13.28$12.25
$12$16$20$24Aug 2025Aug 2027Today$18.14$13.28$12.25

Analyst Sentiment

24ANALYSTS
Buy833%
Hold1146%
Sell521%
The Bottom Line

Sarepta Therapeutics faces potential headwinds at current valuations. Our analysis suggests 35.2% downside risk to our $13.28 target. Investors may want to consider reducing exposure or waiting for a better entry point.

The 24/7 Factor

Base Growth
Conservative growth baseline (reduced to avoid double-counting P/E growth)
1.05×
Sector Momentum
Defensive growth with aging population tailwinds
1.10×
Analyst Consensus
Mixed analyst views
+0.7%
Earnings Growth
Strong earnings acceleration
+3.0%
Volatility Adjustment
Lower volatility stock
+1.6%
Read our full methodology →

5-Year Projection

Long-Term Forecast Optimistic Target Conservative
$12$16$20’26’27’28’29’30’31$18.85$9.34$10.23
$12$16$20’26’27’28’29’30’31$18.85$9.34$10.23

Prediction History

SRPT Price Target History Our Target Stock Price
$12$14$16$18Jul 16Aug 21$12.90$18.79
$12$14$16$18Jul 16Aug 21$12.90$18.79
Date Price Target Stock Price Rating Upside
$12.90 $18.79 SELL −31.3%
$12.68 $18.10 SELL −29.9%
$12.28 $16.78 SELL −26.8%
$16.52 $14.86 BUY +11.1%
$17.17 $15.88 BUY +8.1%
$16.97 $17.23 HOLD −1.5%

Frequently Asked Questions

What is the SRPT stock price prediction for 2030?

Looking ahead to 2030, our model projects SRPT could trade at an average price of $10.93, with a potential range between $8.20 and $13.66. This represents a potential 46.7% decline from today’s price. Long-term forecasts depend heavily on company execution, competitive dynamics, and broader market conditions.

Is SRPT a buy, sell, or hold right now?

24/7 Wall St. currently rates SRPT as a SELL. Significant downside (-35.2%) Among Wall Street analysts, 8 rate it Buy, 11 rate it Hold, and 5 rate it Sell.

What is the SRPT stock price target in an optimistic scenario?

Our optimistic scenario for SRPT projects a price of $18.14 over the next 12 months. Even under favorable conditions, this suggests limited upside from today’s price of $20.51, indicating the stock may currently be trading near or above fair value.

What is the downside risk for SRPT stock?

In our conservative scenario, SRPT could trade as low as $12.25 over the next 12 months, representing a 40.3% decline from current levels. This scenario accounts for potential headwinds including earnings misses, competitive pressures, or broader market weakness.

Projections are estimates based on current data, updated daily. Not investment advice. Learn how we calculate these projections →